1. Use of ultraselective derivate of clonidine for prolonged sedation in term newborns with hypoxic-ischemic encephalopathy
   null null et al, 2019, Acta Medica Leopoliensia CrossRef
2. Upregulation of GLT-1 via PI3K/Akt Pathway Contributes to Neuroprotection Induced by Dexmedetomidine
   Mengyuan Peng et al, 2019, Frontiers in Neurology CrossRef
3. Are GABAergic drugs beneficial in providing neuroprotection after traumatic brain injuries? A comprehensive literature review of preclinical studies
   Shyam Kumar Sudhakar, 2023, Frontiers in Neurology CrossRef
4. Morphological justifi cation of the pathogenesis of angleclosure glaucoma
   N. A. Bakunina et al, 2021, Clinical Medicine (Russian Journal) CrossRef
5. The effects of dexmedetomidine on trauma-induced secondary injury in rat brain
   Ahmet Sen et al, 2024, Neurological Research CrossRef
6. AMPK and its Activator Berberine in the Treatment of Neurodegenerative Diseases
   Siru Qin et al, 2020, Current Pharmaceutical Design CrossRef
7. HSP70 expression before and after treatment and its clinical value in patients with acute angle‑closure glaucoma
   Hong Chen et al, 2021, Experimental and Therapeutic Medicine CrossRef
8. Progress on the Mechanisms and Neuroprotective Benefits of Dexmedetomidine in Brain Diseases
   Zhenxing Tao et al, 2024, Brain and Behavior CrossRef
9. The neuroprotective effect of dexmedetomidine and its mechanism
   Yijun Hu et al, 2022, Frontiers in Pharmacology CrossRef
10. Using of dexmedetomidine in term neonates with hypoxic-ischemic encephalopathy.
    D. Surkov, 2019, Medicni perspektivi (Medical perspectives) CrossRef
11. T Cell-Mediated Autoimmunity in Glaucoma Neurodegeneration
    Lixiang Wang et al, 2021, Frontiers in Immunology CrossRef